On the other hand, hypomethylation of the ASNS gene in T-ALL childhood patients was associated with poor outcomes and resistance to asparaginase, which is a high-dose drug involved in T-ALL therapy [96]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.